Generic Name and Formulations:
Olsalazine sodium 250mg; caps.
Indications for DIPENTUM:
Maintenance of remission in ulcerative colitis in patients intolerant of sulfasalazine.
500mg twice a day with meals.
Monitor urinalysis, BUN, creatinine levels. If diarrhea occurs, monitor serum electrolytes, dehydration status. Pregnancy (Cat.C). Nursing mothers.
Increased prothrombin time with warfarin.
Diarrhea, abdominal pain, rash, pruritus, exacerbation of symptoms of colitis thought to be caused by mesalamine or sulfasalazine.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Adjunctive Therapies for Bipolar Disorder Show Promise, Need More Evidence
- Improving Performance of Everyday Activities Is Critical in Schizophrenia
- Analysis Finds Lithium Maintenance Most Effective as Monotherapy in Bipolar Disorder
- Web-Based Intervention Targets Parental Behaviors That May Affect Adolescent Anxiety, Depression
- Abnormalities of Cortical Thickness in Bipolar Disorder With Auditory Hallucinations
- The Way to the Head May Be Through the Gut: Probiotics for Depression
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Antidepressants Increase Seizure Risk in Youth and Severely Depressed
- Examining Associations Between Diabetes and Effects on Cognition
- Untreated Depression Common in Women of Childbearing Age
- Incidence of Psychiatric Disorders in Rheumatoid Arthritis
- Effect of Antidepressant Class, Dose on Pediatric Anxiety Disorders